Rebecca Byam - Jul 19, 2021 Form 3 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Financial Officer
Signature
/s/ Hing C. Wong, as Attorney-in-Fact for Rebecca A. Byam
Stock symbol
HCWB
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
3
Date filed
7/19/2021, 04:54 PM
Next filing
Jul 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCWB Common Stock 27K Jul 19, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCWB Stock Option (Right to Buy) Jul 19, 2021 Common Stock 108K $0.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These option shares were part of a stock option grant covering 135,000 shares of common stock. 20% of the total shares subject to the stock option grant vested on October 10, 2020; 20% of the total shares subject to the stock option grant will vest on October 10, 2021; 25% of the total shares subject to the stock option grant will vest on October 10, 2022; and 35% of the total shares subject to the stock option grant will vest on October 10, 2023, subject to her continuous service through the applicable vesting date. The option is subject to additional vesting acceleration pursuant to her Employment Agreement.

Remarks:

Exhibit 24.1: Power of Attorney